Shukla R - Search Results

1

Differentiating dental pulp cells via RGD-dendrimer conjugates.

Kim JK, Shukla R, Casagrande L, Sedgley C, Nör JE, Baker JR Jr, Hill EE. Kim JK, et al. Among authors: shukla r. J Dent Res. 2010 Dec;89(12):1433-8. doi: 10.1177/0022034510384870. Epub 2010 Oct 6. J Dent Res. 2010. PMID: 20929719

2

Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures.

Hill E, Shukla R, Park SS, Baker JR Jr. Hill E, et al. Among authors: shukla r. Bioconjug Chem. 2007 Nov-Dec;18(6):1756-62. doi: 10.1021/bc0700234. Epub 2007 Oct 31. Bioconjug Chem. 2007. PMID: 17970585

3

Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.

Shukla R, Thomas TP, Peters J, Kotlyar A, Myc A, Baker JR Jr. Shukla R, et al. Chem Commun (Camb). 2005 Dec 14;(46):5739-41. doi: 10.1039/b507350b. Epub 2005 Oct 10. Chem Commun (Camb). 2005. PMID: 16307130

4

Dendrimer-based tumor cell targeting of fibroblast growth factor-1.

Thomas TP, Shukla R, Kotlyar A, Kukowska-Latallo J, Baker JR Jr. Thomas TP, et al. Among authors: shukla r. Bioorg Med Chem Lett. 2010 Jan 15;20(2):700-3. doi: 10.1016/j.bmcl.2009.11.065. Epub 2009 Dec 3. Bioorg Med Chem Lett. 2010. PMID: 19962894 Free PMC article.

5

RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies.

McNerny DQ, Kukowska-Latallo JF, Mullen DG, Wallace JM, Desai AM, Shukla R, Huang B, Banaszak Holl MM, Baker JR Jr. McNerny DQ, et al. Among authors: shukla r. Bioconjug Chem. 2009 Oct 21;20(10):1853-9. doi: 10.1021/bc900217h. Bioconjug Chem. 2009. PMID: 20711425 Free PMC article.

6

Tumor microvasculature targeting with dendrimer-entrapped gold nanoparticles.

Shukla R, Hill E, Shi X, Kim J, Muniz MC, Sun K, Baker JR Jr. Shukla R, et al. Soft Matter. 2008;4(11):2160-2163. doi: 10.1039/B810885D. Soft Matter. 2008. PMID: 21922025 Free PMC article.

7

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, Kotlyar A, Baker JR Jr. Shukla R, et al. Bioconjug Chem. 2006 Sep-Oct;17(5):1109-15. doi: 10.1021/bc050348p. Bioconjug Chem. 2006. PMID: 16984117

8

Dendrimer-epidermal growth factor conjugate displays superagonist activity.

Thomas TP, Shukla R, Kotlyar A, Liang B, Ye JY, Norris TB, Baker JR Jr. Thomas TP, et al. Among authors: shukla r. Biomacromolecules. 2008 Feb;9(2):603-9. doi: 10.1021/bm701185p. Epub 2008 Jan 15. Biomacromolecules. 2008. PMID: 18193839

9

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb.

Shukla R, Thomas TP, Desai AM, Kotlyar A, Park SJ, Baker JR. Shukla R, et al. Nanotechnology. 2008 Jul 23;19(29):295102. doi: 10.1088/0957-4484/19/29/295102. Epub 2008 Jun 10. Nanotechnology. 2008. PMID: 20686639 Free PMC article.

10

Optical fiber-based in vivo quantification of growth factor receptors.

Thomas TP, Chang YC, Ye JY, Kotlyar A, Cao Z, Shukla R, Qin S, Norris TB, Baker JR Jr. Thomas TP, et al. Among authors: shukla r. Cancer. 2012 Apr 15;118(8):2148-56. doi: 10.1002/cncr.26487. Epub 2011 Aug 25. Cancer. 2012. PMID: 22488668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,953 results

Search Page

Filters